Answers are grounded in this paper and cite their sources.
Introduction: Lung cancer remains the leading cause of cancerrelated mortality worldwide with Non-Small Cell Lung Carcinoma (NSCLC) constituting the majority of cases. Programmed Death Ligand 1 (PD-L1) expression on tumour cells has emerged as a crucial biomarker guiding immunotherapy. However, the relationship between PD-L1 expression and clinicopathological characteristics in NSCLC remains unclear. Aim: To evaluate the distribution of PD-L1 expression in non-small cell lung cancer (NSCLC) and its association with histopathological subtypes. Materials and Methods: The cross-sectional study was conducted over a period of 17 months, from May 2023 to October 2024, in the Department of Pathology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India. A cross-sectional study of 40 NSCLC cases assessed PD-L1 expression by Immunohistochemistry (IHC), classified as negative (<1%), weakly positive (1-50%) or strongly positive (>50%). Associations with age, gender, smoking history, and histological subtype were analysed. The results were analysed using SPSS version 23.0 software. The quantitive data were presented as mean and standard deviation, whereas qualitative data were represented as frequencies and percentages. Chi-square test was used to determine the association between of expression with parameters such as age, gender, histopathological subtypes. Results: Among the 40 NSCLC cases, males accounted for the majority (72.5%). PD-L1 expression was negative in 18 cases (45%), weakly positive in 15 (37.5%) and strongly positive in 7 (17.5%). Although PD-L1 positivity was proportionally higher among females and non-smokers than among males and smokers, respectively, the associations with gender (p=0.0812) and smoking status (p=0.0522) were not statistically significant. SCC demonstrated a higher proportion of strong PD-L1 expression (12.5%) compared with adenocarcinoma (5%); however, this difference was also not statistically significant. No significant association was observed between PD-L1 expression and age. Conclusion: PD-L1 expression in NSCLC varies across demographic and histological factors, with trends suggesting higher expression among females and non-smokers. Larger, multi-center studies are warranted to clarify these associations and support personalised immunotherapy approaches in diverse populations.
No takes yet. Share an insight, caveat, or question.
Raja et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: